LSE:AZN (AstraZeneca PLC)

About AZN

AstraZeneca is a biopharmaceutical business that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three main therapy areas - Respiratory, Inflammation and Autoimmunity (RIA), Cardiovascular and Metabolic Disease (CVMD) and Oncology – as well as in Infection and Neuroscience.

AstraZeneca PLC (LSE: AZN) Latest News

Investing Articles

Events I think that could send AstraZeneca shares rallying in 2021

Given the start of 2021, Jay Yao writes what he thinks are events that could send AstraZeneca shares potentially higher…

Read more »

Investing Articles

My 2 best shares for 2021

As the New Year starts, now is the perfect time to look for investments that should do well this year.…

Read more »

Investing Articles

AstraZeneca shares: Hargreaves Lansdown investors are buying. Should I buy too?

AstraZeneca shares have fallen by more than 25% since last summer. Roland Head has been taking a fresh look. Is…

Read more »

Investing Articles

AstraZeneca’s Covid-19 vaccine approved! Here’s what I’d do now

Approval for AstraZeneca’s vaccine brings the UK a step closer to winning the fight against Covid-19. But is there a…

Read more »

Investing Articles

Will the AstraZeneca share price be the largest FTSE 100 riser in 2021?

The AstraZeneca share price has performed well under Pascal Soriot. After its acquisition of Alexion, will it rise further in…

Read more »

Investing Articles

The 2 UK shares I would buy before the year ends

As 2020 draws to a close, here are the top two UK shares I would buy before the New Year.

Read more »

Investing Articles

The AstraZeneca share price outperformed the FTSE 100 in 2020

Covid-19 gave the AstraZeneca share price an early boost. That fell away, but iits shares look set to end 2020…

Read more »

Investing Articles

I’d buy GlaxoSmithKline and AstraZeneca given this huge AI breakthrough

Despite the tepid market reaction, Jay Yao writes why he thinks the recent AI protein folding news is bullish for…

Read more »

Investing Articles

Here’s what I think the AstraZeneca vaccine means for the dividend

Jay Yao writes how he thinks AstraZeneca’s Covid-19 vaccine candidate could affect the company’s dividend payments in the coming years.

Read more »

Investing Articles

The top 2 UK shares I would buy today

As Christmas approaches, here are my top two UK shares I would pick up today.

Read more »

Investing Articles

What I think AstraZeneca’s purchase of Alexion means for the dividend

Jay Yao writes how he thinks AstraZeneca’s recent agreement to buy Alexion Pharmaceuticals affects the company’s dividend.

Read more »

Investing Articles

Can the AstraZeneca share price touch £100? 

The AstraZeneca share price has had a standout 2020. But is the best behind it or is there more to…

Read more »